Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol vs Nifedipine for Postpartum Hypertension
NCT02426177Phase 3Unknown
- Sponsor
- Dow University of Health Sciences
- Start
- May 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of labetalol, nifedipine in hypertension (HTN), sponsored by Dow University of Health Sciences. Status: unknown.
02
Drugs
labetalolnifedipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02426177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02426177.